Inventor
KOJI TAMADA
Inventor
JP
Overview
Patents· 13 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
C12NMicroorganisms or enzymes19%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
12,594,294Therapeutic and prophylactic agent for glioma, brain tumor malignancy marker, brain tumor prognostic marker, method for determining malignancy and prognosis of brain tumor and antibody inhibiting tumor proliferation202612,448,413HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell202512,129,291Anti-GPC3 antibody202412,005,103Universal anti-tag chimeric antigen receptor-expressing t cells and methods of treating cancer202411,931,381Immunocompetent cell and expression vector expressing regulatory factors of immune function202411,759,518Medicine for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein202311,718,663Anti-GPC3 antibody202311,618,770MUC1-derived peptide, and pharmaceutical composition for treatment or prevention of cancer, immunity-inducing agent and method for manufacturing antigen presenting cell using same202311,617,765Enhancer for T-cells or B-cells having memory function, malignant tumor recurrence inhibitor, and inducer for inducing memory function in T-cells or B-cells202311,491,204Composition comprising poly I:C and LAG-3-IGG fusion protein202211,337,997Immunocompetent cell and expression vector expressing regulatory factors of immune function202211,304,997HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell202211,291,718Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to UNIV YAMAGUCHI (5)· patent assignee history
2022Patents assigned to CYTLIMIC INC (3)· patent assignee history
2022–2026Based in JP· patent location history
2023–2025Patents assigned to NEC CORP (3)· patent assignee history
2023–2024Patents assigned to NAT CANCER CT (2)· patent assignee history
2023–2024Patents assigned to NOILE IMMUNE BIOTECH INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV YAMAGUCHI | 5 | 2022–2024 |
| CYTLIMIC INC | 3 | 2022 |
| NEC CORP | 3 | 2023–2025 |
| NAT CANCER CT | 2 | 2023–2024 |
| NOILE IMMUNE BIOTECH INC | 2 | 2023–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| JP | 13 | 2022–2026 |